Literature DB >> 4058882

Prevalence of cataracts in a population-based study of persons with diabetes mellitus.

B E Klein, R Klein, S E Moss.   

Abstract

Persons with diabetes mellitus have been found to be at increased risk of developing cataracts when compared with nondiabetic persons. This report describes the study of characteristics which may be related to this problem in a population-based sample of diabetic persons. Prevalence of surgical aphakia and cataract increased with increasing age in both younger and older onset diabetic persons. Females had higher rates than males. In multivariate analyses, for younger onset persons, longer duration of diabetes, older age at examination, increased severity of retinopathy, diuretic usage and higher glycosylated hemoglobin levels were significantly associated with greater prevalence of cataract. In older onset persons, age at examination, increased severity of retinopathy, diuretic usage, lower intraocular pressure, smoking and lower diastolic blood pressure were significantly associated with greater prevalence of cataract. Longitudinal data concerning the relationship of some of these characteristics to subsequent development or progression of cataract are necessary before considering the possibility of preventive trials in this condition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4058882     DOI: 10.1016/s0161-6420(85)33877-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  56 in total

1.  Progression of diabetic retinopathy following cataract surgery: can it be prevented?

Authors:  D W Flanagan
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

Review 2.  Optical quality of the diabetic eye: a review.

Authors:  A M Calvo-Maroto; R J Perez-Cambrodí; C Albarán-Diego; A Pons; A Cerviño
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

3.  Community-based study of cataracts among type 2 diabetics in Kinmen.

Authors:  Tao-Hsin Tung; Jorn-Hon Liu; Fenq-Lih Lee; Shih-Jen Chen; Ching-Yao Tsai; Pesus Chou
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Intensive diabetes therapy and ocular surgery in type 1 diabetes.

Authors:  Lloyd Paul Aiello; Wanjie Sun; Arup Das; Sapna Gangaputra; Szilard Kiss; Ronald Klein; Patricia A Cleary; John M Lachin; David M Nathan
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

5.  Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease.

Authors:  Jesús Ruberte; Eduard Ayuso; Marc Navarro; Ana Carretero; Víctor Nacher; Virginia Haurigot; Mónica George; Cristina Llombart; Alba Casellas; Cristina Costa; Assumpció Bosch; Fatima Bosch
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  Changes of tear film and tear secretion after phacoemulsification in diabetic patients.

Authors:  Xi Liu; Yang-shun Gu; Ye-sheng Xu
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

7.  Diabetic cataract-pathogenesis, epidemiology and treatment.

Authors:  Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  J Ophthalmol       Date:  2010-06-17       Impact factor: 1.909

8.  The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.

Authors:  Morteza Entezari; Alireza Ramezani; Homayon Nikkhah; Mehdi Yaseri
Journal:  Int Ophthalmol       Date:  2016-03-14       Impact factor: 2.031

9.  Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema.

Authors:  Carl W Baker; Talat Almukhtar; Neil M Bressler; Adam R Glassman; Sandeep Grover; Stephen J Kim; Timothy J Murtha; Michael E Rauser; Cynthia Stockdale
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

10.  The transparency of the lens: a comparison between diabetic and non-diabetic patients.

Authors:  S L Franklin; J Flammer; R De Natale; C Rutishuser
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.